Abbott Laboratories (BMV:ABT)

Mexico flag Mexico · Delayed Price · Currency is MXN
2,370.00
-50.50 (-2.09%)
At close: Jul 31, 2025, 2:00 PM CST
-2.09%
Market Cap4.19T
Revenue (ttm)812.96B
Net Income (ttm)262.66B
Shares Outn/a
EPS (ttm)150.33
PE Ratio15.96
Forward PE23.38
Dividend45.65 (1.93%)
Ex-Dividend DateJul 15, 2025
Volume100
Average Volume433
Open2,411.00
Previous Close2,420.50
Day's Range2,370.00 - 2,411.00
52-Week Range1,938.00 - 2,915.60
Beta0.73
RSI48.28
Earnings DateJul 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]

Sector Healthcare
Founded 1888
Employees 114,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol ABT
Full Company Profile

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD Financial Statements

News

There is no news available yet.